We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
General Motors
GM
$77B
| $138M | 0.05% |
4,105,801
-263,248
| -6% | -$9.73M |
|
302
Zimmer Biomet
ZBH
$18.4B
| $137M | 0.05% |
1,077,905
-260,720
| -19% | -$30.3M |
|
303
United Therapeutics
UTHR
$23B
| $135M | 0.05% |
485,288
-25,106
| -5% | -$6.34M |
|
304
Ciena
CIEN
$58B
| $135M | 0.05% |
2,638,619
-692,637
| -21% | -$31.3M |
|
305
Charter Communications
CHTR
$18.2B
| $134M | 0.05% |
396,597
-85,868
| -18% | -$30.2M |
|
306
Marriott International
MAR
$92.9B
| $134M | 0.05% |
899,102
-260,713
| -22% | -$40.1M |
|
307
MGM Resorts International
MGM
$11.2B
| $132M | 0.05% |
3,942,465
+2,986,980
| +313% | +$103M |
|
308
Snowflake
SNOW
$114B
| $132M | 0.05% |
920,120
+44,228
| +5% | +$6.75M |
|
309
Arcos Dorados Holdings
ARCO
$1.73B
| $131M | 0.05% |
15,705,149
-458,283
| -3% | -$3.43M |
|
310
CrowdStrike
CRWD
$217B
| $128M | 0.05% |
4,859,244
+294,780
| +6% | +$10.1M |
|
311
Allstate
ALL
$67.7B
| $128M | 0.05% |
941,508
-1,626,027
| -63% | -$213M |
|
312
Dow Inc
DOW
$21.3B
| $127M | 0.05% |
2,524,502
-6,390
| -0.3% | -$312K |
|
313
Ingersoll Rand
IR
$33.9B
| $126M | 0.05% |
2,415,989
-839,663
| -26% | -$42.9M |
|
314
Masco
MAS
$15.3B
| $126M | 0.05% |
2,697,091
-47,003
| -2% | -$2.27M |
|
315
GE Aerospace
GE
$384B
| $126M | 0.05% |
3,794,066
+56,870
| +2% | +$2.8M |
|
316
Cintas
CTAS
$81.3B
| $124M | 0.05% |
1,100,932
-218,120
| -17% | -$23.6M |
|
317
FedEx
FDX
$75.4B
| $124M | 0.05% |
713,785
+10,914
| +2% | +$1.81M |
|
318
Kroger
KR
$34.7B
| $124M | 0.05% |
2,771,587
+27,215
| +1% | +$1.25M |
|
319
ResMed
RMD
$30.4B
| $123M | 0.05% |
588,659
+24,750
| +4% | +$5.44M |
|
320
Roblox
RBLX
$26.8B
| $122M | 0.05% |
4,304,096
-186,164
| -4% | -$6.54M |
|
321
TransDigm Group
TDG
$68.1B
| $122M | 0.05% |
193,402
-45,777
| -19% | -$27M |
|
322
MSCI
MSCI
$41B
| $121M | 0.05% |
260,744
-5,324
| -2% | -$2.48M |
|
323
Oneok
OKE
$54.5B
| $121M | 0.05% |
1,841,077
-415,917
| -18% | -$25.6M |
|
324
Equitable Holdings
EQH
$14.2B
| $121M | 0.05% |
4,212,650
-517,366
| -11% | -$15.3M |
|
325
Enphase Energy
ENPH
$5.48B
| $121M | 0.05% |
455,719
+5,222
| +1% | +$1.52M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.